BRAFV600E mutations and immunohistochemical expression of VE1 protein in low-grade serous neoplasms of the ovary

Histopathology
Gulisa TurashviliRajmohan Murali

Abstract

The most common BRAF mutation in ovarian low-grade serous neoplasms (LGSNs) involves substitution of valine by glutamic acid at position 600 (V600E). Small studies have demonstrated high specificity of immunohistochemistry with mutation-specific monoclonal antibody VE1. We sought to investigate the expression of VE1 protein in LGSNs and its correlation with BRAF mutation-associated histological features and BRAF mutation status. We reviewed pathology reports and available slides from ovarian serous borderline tumours (SBTs) and low-grade serous carcinomas (LGSCs) diagnosed between 2000 and 2012. VE1 immunohistochemistry was performed on formalin-fixed, paraffin-embedded tissue sections. Tumours with ≥50% positive cells were considered positive. Of 121 LGSNs, there were 73 SBTs, eight SBTs with micropapillary features (mpSBT) and 40 LGSCs (22 primary, 18 metastatic). VE1 was positive in 52% (38 of 73) of SBTs and 9% (two of 22) of primary LGSCs, and in none of the mpSBTs and metastatic LGSCs (P < 0.0001). Of 76 tumours with known mutation status, 42 (55%) harboured mutations, including BRAFV600E (26, 34%), KRASG12D (eight, 11%), and KRASG12V (eight, 11%). BRAFV600E mutations were present in 48% (25 of 52) of SBTs and 5% (one of ...Continue Reading

References

Mar 20, 2003·Journal of the National Cancer Institute·Gad SingerIe-Ming Shih
Apr 28, 2004·The American Journal of Pathology·Ie-Ming Shih, Robert J Kurman
Jun 8, 2006·Methods in Enzymology·Richard WoosterMichael R Stratton
Aug 2, 2006·Obstetrics and Gynecology·David M GershensonDiane C Bodurka
Sep 10, 2008·The American Journal of Surgical Pathology·Anna YemelyanovaRobert J Kurman
Apr 14, 2009·Gynecologic Oncology·David M GershensonJohn J Kavanagh
Dec 4, 2009·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Marjolijn B VerbruggenJosephine C Dorsman
Aug 31, 2010·The American Journal of Pathology·Kwong-Kwok WongDavid M Gershenson
Dec 8, 2010·Pathology Oncology Research : POR·Ildikó VereczkeyErika Tóth
Nov 1, 2011·PloS One·Hazem El-OstaRazelle Kurzrock
Nov 22, 2011·The Journal of Pathology·Siân JonesIe-Ming Shih
May 30, 2013·American Society of Clinical Oncology Educational Book·David M Gershenson
Jul 1, 2014·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Rachel N GrishamCarol Aghajanian
Dec 3, 2014·Gynecologic Oncology·Erin K CraneDavid M Gershenson
Aug 20, 2015·The New England Journal of Medicine·David M HymanJosé Baselga
Oct 21, 2015·British Journal of Cancer·David M GershensonKwong-Kwok Wong
Mar 26, 2016·The American Journal of Pathology·Robert J Kurman, Ie-Ming Shih
May 4, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A Malpica, K-K Wong
May 4, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D M Gershenson
Jul 30, 2016·Pharmacogenomics·Jennifer McLachlanSusana Banerjee
May 11, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Pawel SadleckiMalgorzata Walentowicz-Sadlecka
Jan 1, 2018·Pathology·Anais Malpica, Teri A Longacre

❮ Previous
Next ❯

Citations

Oct 3, 2019·The Journal of Pathology·Michael Herman Chui, Ie-Ming Shih
Sep 19, 2018·Current Treatment Options in Oncology·Rachel N Grisham, Gopa Iyer
Oct 13, 2020·Upsala Journal of Medical Sciences·Bengt TholanderGustav J Ullenhag

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Applied Immunohistochemistry & Molecular Morphology : AIMM
Matthias PreusserPeter Birner
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists
Jaime Prat
© 2022 Meta ULC. All rights reserved